However, further genetic molecular assays with cytokine-dependent cells lacking Dynamin or expressing specific mutants of Dynamin will be required to characterize the specificity of Dynole 34-2 for targeting Dynamin in the biological context of leukemia. The gene discussed is DNM1; the disease is leukemia.